Companies
S&P 500Health Care· USA
TECH
Status-Quo-PlayerBio-Techne
$57.53
+3.54%
Open $55.42·Prev $55.57
as of 13 Apr
STATUS-QUO-PLAYER
Power Core
The moat in one sentence: Bio-Techne's power derives from being the cited standard in biological reagents, where switching suppliers introduces scientific risk that researchers, journals, and regulators are structurally unwilling to accept.
Published1 Apr 2026
UniverseS&P 500
SectorHealth Care
↑
Direction of Movement
Steady Core Recovery, Growth Segments Await Critical Mass
ROC 200
+2.9%
Referenced in 1 other analysis